Stryker (SYK -3.80%), a leading global medical technology company, reported financial results on July 31, 2025. The company delivered several key beats: Net sales (GAAP) reached $6.0 billion, topping analyst expectations of$5.94 billion (GAAP), and adjusted earnings per share (non-GAAP) came in at $3.13, ahead of the$3.07 non-GAAP consensus. This performance reflected double-digit growth in both sales and profits compared to the same period last year. Stryker also raised its full-year 2025 guidance for or ...